Concepedia

Bjoern Bielec

BB

Statistics

Publications

5

Citations

137

H-Index

5

Active since

2015

Affiliations

University of Vienna(Current)

Medical University of Vienna

Translational Research in Oncology

Comprehensive Cancer Center Vienna

Bjoern Bielec is an author at University of Vienna specializing in medicinal chemistry, pharmacology, and pharmacy.

ORCID

Publications per year

2015–2020

5

Publications

5

The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition

Sonja Hager, Katharina Korbula, Bjoern Bielec et al. · Cell Death and Disease · 2018 · 74 citations · Full text

, , +13

Understanding the metabolism of the anticancer drug Triapine: electrochemical oxidation, microsomal incubation and in vivo analysis using LC-HRMS

Karla Pelivan, Lisa M. Frensemeier, Uwe Kärst et al. · The Analyst · 2017 · 19 citations · Full text

, , +17

Development and biological investigations of hypoxia-sensitive prodrugs of the tyrosine kinase inhibitor crizotinib

Bjoern Bielec, Hemma Schueffl, Alessio Terenzi et al. · Bioorganic Chemistry · 2020 · 19 citations · Full text

, , +16

Mechanistic aspects of the direct C-acylation of cyclic 1,3-diones with various unactivated carboxylic acids

Michal Kohout, Bjoern Bielec, Patrick Steindl et al. · Tetrahedron · 2015 · 14 citations

, , +10

Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib

Bjoern Bielec, Isabella Poetsch, Esra Ahmed et al. · Molecules · 2020 · 11 citations · Full text

, , +16

1–5 of 5